Skip to content
Open in App
PharmaEssentia logo

PharmaEssentia

web2

PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, suppleme...

Symbol · 6446
Company profile

About

PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan. Its products include BESREMi, an interferon therapy indicated for polycythemia vera, essential thrombocythemia, PMF, and adult T-cell leukemias. The company also develops Ropeg + anti PD-1; PEG-IL-2 (P11838); PEG-Cytokines; PD-1-IL-2v; ADC; ADCS; NY-ESO-1 TCR-T; and Novel TCR-T for the treatment of solid tumor and immunology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

CT

Ching-Leou Teng

Chairman & Chief Pharmaceutical Officer

Company leadership profile.

KL

Ko-Chung Lin

Founder, CEO, Chief Strategy Officer & Director

Company leadership profile.

CH

Chan-Kou Hwang

President, GM & Director

Company leadership profile.

NK

Norio Komatsu

Chairperson of Japan

Company leadership profile.

JC

Jinn-Der Chang

Director

Company leadership profile.

JT

Jien-Heh Tien

Independent Director

Company leadership profile.

MH

Ming-Chuan Hsieh

Independent Director

Company leadership profile.

SL

Shen-Yi Lee

Director

Company leadership profile.

CH

ChenJung Hsiao

Director

Company leadership profile.

JR

Jeffrey R. Williams

Independent Director

Company leadership profile.

CL

Ching-Tsun Liu

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated PharmaEssentia.

Orbitrum research

Experts evaluating PharmaEssentia

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment